Bhasin Appointed Site Director for HC-CRC
Shalender Bhasin, MD, of the Department of Medicine, has been appointed as site director for the Harvard Catalyst-Clinical Research Center (HC-CRC) at BWH. He succeeds Gordon Williams, MD, who has most ably led the Clinical Research Center for more than 30 years.
Bhasin is an internationally recognized clinical investigator with expertise in androgen biology, complex clinical trials, function-promoting therapies for age-related functional decline and hormone assays. He is the director of the Research Program in Men’s Health: Aging and Metabolism at BWH; he also serves as the director of the National Institute on Aging-funded Boston Claude D. Pepper Older Americans Independence Center for Function Promoting Therapies at BWH.
Bhasin believes that the National Institutes of Health’s directional transitions in clinical research towards translation and patient-centeredness provide historic opportunities to integrate mechanism-based, as well as applied research, with health care delivery.
Giordano Joins BWH Department of Medicine
Kevin Giordano, MBA, has been appointed executive administrator of BWH’s Department of Medicine. He began Sept. 3.
In this role, Giordano will lead senior administrative staff and co-manage the department’s division administrators. He will also be responsible for the administrative functions of the department, including clinical operations, finance, education, research administration, quality and faculty services.
Giordano most recently served as executive director for the Dana-Farber/Brigham and Women’s Cancer Center in clinical affiliation with South Shore Hospital. Prior to this role, he was the administrative director of the BWH Division of Plastic Surgery, director of the Cancer Intelligence Program at Sg2, and group administrator for the Division of Hematologic Neoplasia/Malignancies at the Dana-Farber Cancer Institute.
Giordano received his BS in Finance and Information Systems from Boston College and his MBA from Yale University.